BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26091447)

  • 1. Combination Therapy of Metformin and Statin May Decrease Hepatocellular Carcinoma Among Diabetic Patients in Asia.
    Chen HH; Lin MC; Muo CH; Yeh SY; Sung FC; Kao CH
    Medicine (Baltimore); 2015 Jun; 94(24):e1013. PubMed ID: 26091447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin and Hepatocellular Carcinoma Risk Reduction in Diabetic Patients with Chronic Hepatitis C: Fact or Fiction?
    Sacco M; Ribaldone DG; Saracco GM
    Viruses; 2023 Dec; 15(12):. PubMed ID: 38140692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin does not improve survival in patients with hepatocellular carcinoma.
    Bhat M; Chaiteerakij R; Harmsen WS; Schleck CD; Yang JD; Giama NH; Therneau TM; Gores GJ; Roberts LR
    World J Gastroenterol; 2014 Nov; 20(42):15750-5. PubMed ID: 25400459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus and metformin in hepatocellular carcinoma.
    Fujita K; Iwama H; Miyoshi H; Tani J; Oura K; Tadokoro T; Sakamoto T; Nomura T; Morishita A; Yoneyama H; Masaki T
    World J Gastroenterol; 2016 Jul; 22(27):6100-13. PubMed ID: 27468203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin use as a moderator of metformin effect on risk for prostate cancer among type 2 diabetic patients.
    Lehman DM; Lorenzo C; Hernandez J; Wang CP
    Diabetes Care; 2012 May; 35(5):1002-7. PubMed ID: 22456867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy.
    Tsai PC; Huang CF; Yeh ML; Hsieh MH; Kuo HT; Hung CH; Tseng KC; Lai HC; Peng CY; Wang JH; Chen JJ; Lee PL; Chien RN; Yang CC; Lo GH; Kao JH; Liu CJ; Liu CH; Yan SL; Lin CY; Su WW; Chu CH; Chen CJ; Tung SY; Tai CM; Lin CW; Lo CC; Cheng PN; Chiu YC; Wang CC; Cheng JS; Tsai WL; Lin HC; Huang YH; Chen CY; Huang JF; Dai CY; Wan-Long WL; Bair MJ; Yu ML;
    Clin Mol Hepatol; 2024 Apr; ():. PubMed ID: 38637957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of metformin in the diagnosis, prevention, and treatment of hepatocellular carcinoma.
    Xiong S; Liu W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):364-373. PubMed ID: 35545330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins intake and risk of liver cancer: A dose-response meta analysis of prospective cohort studies.
    Yi C; Song Z; Wan M; Chen Y; Cheng X
    Medicine (Baltimore); 2017 Jul; 96(27):e7435. PubMed ID: 28682909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can metformin improve 'the tomorrow' of patients treated for oesophageal cancer?
    Van De Voorde L; Janssen L; Larue R; Houben R; Buijsen J; Sosef M; Vanneste B; Schraepen MC; Berbée M; Lambin P
    Eur J Surg Oncol; 2015 Oct; 41(10):1333-9. PubMed ID: 26091848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
    Nayan M; Bhindi B; Yu JL; Hermanns T; Mohammed A; Hamilton RJ; Finelli A; Jewett MA; Zlotta AR; Fleshner NE; Kulkarni GS
    Urol Oncol; 2015 Sep; 33(9):386.e7-13. PubMed ID: 26097049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of antihyperglycaemic drug regimens added to metformin and sulphonylurea therapy in Type 2 diabetes: a network meta-analysis.
    Mearns ES; Saulsberry WJ; White CM; Kohn CG; Lemieux S; Sihabout A; Salamucha I; Coleman CI
    Diabet Med; 2015 Dec; 32(12):1530-40. PubMed ID: 26104021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intensive lipid-lowering therapy on coronary plaques composition in patients with acute myocardial infarction: Assessment with serial coronary CT angiography.
    Auscher S; Heinsen L; Nieman K; Vinther KH; Løgstrup B; Møller JE; Broersen A; Kitslaar P; Lambrechtsen J; Egstrup K
    Atherosclerosis; 2015 Aug; 241(2):579-87. PubMed ID: 26115069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin in breast cancer - an evolving mystery.
    Camacho L; Dasgupta A; Jiralerspong S
    Breast Cancer Res; 2015 Jun; 17(1):88. PubMed ID: 26111812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From a fish tank injury to hospital haemodialysis: the serious consequences of drug interactions.
    Hill FJ; McCloskey SJ; Sheerin N
    BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26106178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin as Initial Oral Therapy in Type 2 Diabetes.
    Stern RJ; Murphy EJ
    JAMA; 2015 Jun 23-30; 313(24):2484-5. PubMed ID: 26103032
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of Menopause on Pharmacokinetics of Rosuvastatin Compared with Premenopausal Women.
    Nazir S; Iqbal Z; Nasir F
    Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):505-9. PubMed ID: 26099962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study.
    Hung SC; Chang YK; Liu JS; Kuo KL; Chen YH; Hsu CC; Tarng DC
    Lancet Diabetes Endocrinol; 2015 Aug; 3(8):605-14. PubMed ID: 26094107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Patient's care and management of dyslipidemia at discharge after an acute coronary syndrome in the clinical practice in Spain: The SINCOPA study].
    Murga N; Ruiz E; Pascual V;
    Clin Investig Arterioscler; 2015; 27(6):272-9. PubMed ID: 26100329
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.